AARP Eye Center
prescription drug prices
AARP and dozens of other advocacy groups are pushing for legislation that would lower drug prices through more competition and transparency.
We endorsed legislation that would make drugmakers disclose profits and expenses when raising prices or launching drugs with high price tags.
A new law that addresses high prescription drug prices and out-of-pocket costs will help improve the affordability of insulin for millions of diabetic Medicare beneficiaries, and new research sheds light on its potential impact.
AARP CEO Jo Ann Jenkins traveled to the White House to celebrate the signing of the Inflation Reduction Act, which will lower prescription drug costs.
The Inflation Reduction Act will lower drug prices for millions of Americans, according to experts who joined AARP for our latest tele-town hall.
Senate Majority Leader Chuck Schumer joined an AARP event to discuss the recently enacted Inflation Reduction Act, which will lower drug prices.
AARP CEO Jo Ann Jenkins is thanking members for their support passing a bill lowering the price of prescription drugs for millions of Americans.
AARP is thanking lawmakers for passing the Inflation Reduction Act, which includes historic drug price reforms that will make prescriptions cheaper.
AARP CEO Jo Ann Jenkins implored members of the U.S. Senate to pass a prescription drug bill during an appearance Wednesday on Capitol Hill.
En español | AARP launched a $1 million TV ad buy on July 21 calling on lawmakers to support Medicare reform legislation that would let the federal program directly negotiate prices with pharmaceutical companies.